These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2523717)

  • 21. Polymerase chain reaction evidence for human immunodeficiency virus 1 neutralization by passive immunization in patients with AIDS and AIDS-related complex.
    Karpas A; Hewlett IK; Hill F; Gray J; Byron N; Gilgen D; Bally V; Oates JK; Gazzard B; Epstein JE
    Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7613-7. PubMed ID: 2145579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative analysis of CD4-4B4 and CD4-2H4 lymphocyte subpopulations in HIV negative homosexual, HIV seropositive and healthy subjects.
    Vuillier F; Lapresle C; Dighiero G
    Clin Exp Immunol; 1988 Jan; 71(1):8-12. PubMed ID: 2964959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular and humoral immunity in various cohorts of male homosexuals in relation to infection with human immunodeficiency virus.
    Roos MT; Miedema F; Eeftinck Schattenkerk JK; de Wolf F; Goudsmit J; Lange JM; Danner SA; Out TA; Schellekens PT
    Neth J Med; 1989 Apr; 34(3-4):132-41. PubMed ID: 2524673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV-1-infected patients with envelope-specific lymphoproliferation or long-term nonprogression lack antibodies suppressing glycoprotein 120 antigen presentation.
    Chien PC; Chen D; Chen PD; Tuen M; Cohen S; Migueles SA; Connors M; Rosenberg E; Malhotra U; Gonzalez C; Hioe CE
    J Infect Dis; 2004 Mar; 189(5):852-61. PubMed ID: 14976603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies to the HIV-1 Tat protein correlated with nonprogression to AIDS: a rationale for the use of Tat toxoid as an HIV-1 vaccine.
    Zagury JF; Sill A; Blattner W; Lachgar A; Le Buanec H; Richardson M; Rappaport J; Hendel H; Bizzini B; Gringeri A; Carcagno M; Criscuolo M; Burny A; Gallo RC; Zagury D
    J Hum Virol; 1998; 1(4):282-92. PubMed ID: 10195253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low T-cell responsiveness to activation via CD3/TCR is a prognostic marker for acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus-1 (HIV-1)-infected men.
    Schellekens PT; Roos MT; De Wolf F; Lange JM; Miedema F
    J Clin Immunol; 1990 Mar; 10(2):121-7. PubMed ID: 2140115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma viremia in human immunodeficiency virus infection.
    Coombs RW; Collier AC; Allain JP; Nikora B; Leuther M; Gjerset GF; Corey L
    N Engl J Med; 1989 Dec; 321(24):1626-31. PubMed ID: 2511447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunological abnormalities in asymptomatic homosexual men: correlation with antibody to HTLV-III and sequential changes over two years.
    Frazer IH; Mackay IR; Crapper RM; Jones B; Gust ID; Sarngadharan MG; Campbell DC; Ungar B
    Q J Med; 1986 Oct; 61(234):921-33. PubMed ID: 3498182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of correlation between human herpesvirus-6 infection and the course of human immunodeficiency virus infection.
    Spira TJ; Bozeman LH; Sanderlin KC; Warfield DT; Feorino PM; Holman RC; Kaplan JE; Fishbein DB; Lopez C
    J Infect Dis; 1990 Mar; 161(3):567-70. PubMed ID: 2155975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human immunodeficiency virus isolates from asymptomatic homosexual men and from AIDS patients have distinct biologic and genetic properties.
    Balachandran R; Thampatty P; Enrico A; Rinaldo C; Gupta P
    Virology; 1991 Jan; 180(1):229-38. PubMed ID: 1701946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between HTLV-III neutralizing antibody and clinical status of pediatric acquired immunodeficiency syndrome (AIDS) and AIDS-related complex cases.
    Robert-Guroff M; Oleske JM; Connor EM; Epstein LG; Minnefor AB; Gallo RC
    Pediatr Res; 1987 Jun; 21(6):547-50. PubMed ID: 3474582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longitudinal patterns of HIV type 1 RNA among individuals with late disease progression.
    Gange SJ; Mellors JW; Lau B; Detels R; Phair JP; Muñoz A; Margolick JB
    AIDS Res Hum Retroviruses; 2001 Sep; 17(13):1223-9. PubMed ID: 11559421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective alterations in immunoregulatory lymphocyte subsets in early HIV (human T-lymphotropic virus type III/lymphadenopathy-associated virus) infection.
    Giorgi JV; Nishanian PG; Schmid I; Hultin LE; Cheng HL; Detels R
    J Clin Immunol; 1987 Mar; 7(2):140-50. PubMed ID: 2883197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Human immunodeficiency virus-1 gag specific CD8+ T cell responses in long-term nonprogressors and acquired immunodeficiency syndrome patients].
    Zhang HW; Qiu ZF; Li TS
    Zhonghua Nei Ke Za Zhi; 2004 Dec; 43(12):911-4. PubMed ID: 15730736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Dynamics of the antibody response and p24 antigenemia in HIV-1 infected individuals in Czechoslovakia].
    Kopecká D; Brůcková M; Stanková M; Syrůcek L; Vojtĕchovský K; Petkov V
    Cesk Epidemiol Mikrobiol Imunol; 1990 Mar; 39(2):65-73. PubMed ID: 2142624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus. Presence at different clinical stages.
    Ljunggren K; Böttiger B; Biberfeld G; Karlson A; Fenyö EM; Jondal M
    J Immunol; 1987 Oct; 139(7):2263-7. PubMed ID: 3498755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Possible beneficial effects of neutralizing antibodies and antibody-dependent, cell-mediated cytotoxicity in human immunodeficiency virus infection.
    Sawyer LA; Katzenstein DA; Hendry RM; Boone EJ; Vujcic LK; Williams CC; Zeger SL; Saah AJ; Rinaldo CR; Phair JP
    AIDS Res Hum Retroviruses; 1990 Mar; 6(3):341-56. PubMed ID: 1971182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 90K protein: a new predictor marker of disease progression in human immunodeficiency virus infection.
    Natoli C; Dianzani F; Mazzotta F; Balocchini E; Pierotti P; Antonelli G; Iacobelli S
    J Acquir Immune Defic Syndr (1988); 1993 Apr; 6(4):370-5. PubMed ID: 8095982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct comparison of the relationship between clinical outcome and change in CD4+ lymphocytes in human immunodeficiency virus-positive homosexual men and injecting drug users.
    Margolick JB; Muñoz A; Vlahov D; Astemborski J; Solomon L; He XY; Nelson KE; Saah AJ
    Arch Intern Med; 1994 Apr; 154(8):869-75. PubMed ID: 7908795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphocyte transformation response to pokeweed mitogen as a predictive marker for development of AIDS and AIDS related symptoms in homosexual men with HIV antibodies.
    Hofmann B; Lindhardt BO; Gerstoft J; Petersen CS; Platz P; Ryder LP; Odum N; Dickmeiss E; Nielsen PB; Ullman S
    Br Med J (Clin Res Ed); 1987 Aug; 295(6593):293-6. PubMed ID: 2820544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.